430 fundamentals
An in-depth look to TERNS PHARMACEUTICALS INC operating, investing, and financing activities
430 free cash flow for Q3 24 is -14.85 M EUR. For 2023, 430 free cash flow was -61.41 M EUR and operating cash flow was -61.37 M EUR.
Q4 '19
Q1 '20
Q2 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q4 '19
Q1 '20
Q2 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM